Your browser doesn't support javascript.
loading
Isochlorogenic Acid C Alleviates High-Fat Diet-Induced Hyperlipemia by Promoting Cholesterol Reverse Transport.
Zheng, Liuyi; Lin, Guangyao; Li, Ruyue; Gan, Haining; Huang, Xuejun; Yao, Nan; Cai, Dake; Zhao, Ziming; Hu, Zixuan; Li, Minyi; Xu, Huazhen; Li, Leyi; Peng, Sha; Zhao, Xinxin; Lai, Yijing; Chen, Yuxing; Huang, Dane.
Afiliación
  • Zheng L; The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Lin G; Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine, Guangdong Provincial Second Hospital of Traditional Chinese Medicine (Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine), Guangzhou, China.
  • Li R; School of Marxism, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Gan H; The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Huang X; Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine, Guangdong Provincial Second Hospital of Traditional Chinese Medicine (Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine), Guangzhou, China.
  • Yao N; Department of Pharmacy, Zhengzhou People's Hospital, Zhengzhou, China.
  • Cai D; The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Zhao Z; Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine, Guangdong Provincial Second Hospital of Traditional Chinese Medicine (Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine), Guangzhou, China.
  • Hu Z; The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Li M; Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine, Guangdong Provincial Second Hospital of Traditional Chinese Medicine (Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine), Guangzhou, China.
  • Xu H; The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Li L; Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine, Guangdong Provincial Second Hospital of Traditional Chinese Medicine (Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine), Guangzhou, China.
  • Peng S; The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Zhao X; Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine, Guangdong Provincial Second Hospital of Traditional Chinese Medicine (Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine), Guangzhou, China.
  • Lai Y; The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Chen Y; Guangdong Provincial Key Laboratory of Research and Development in Traditional Chinese Medicine, Guangdong Provincial Second Hospital of Traditional Chinese Medicine (Guangdong Provincial Engineering Technology Research Institute of Traditional Chinese Medicine), Guangzhou, China.
  • Huang D; The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Front Pharmacol ; 13: 881078, 2022.
Article en En | MEDLINE | ID: mdl-35959429

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza